Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.
about
Changing perceptions in osteoporosis.The assessment of fracture risk.Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial.Treatment induced changes of bone density and relative risk of vertebral fracture.The 2002 Canadian bone densitometry recommendations: take-home messages.Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosisEvaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosisClinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not?The role of dietary calcium in bone health.Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis.Denosumab in postmenopausal osteoporosis: what the clinician needs to know.Examining the relationship between bone mineral density and fracture risk reduction during pharmacologic treatment of osteoporosis.Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality.Clinical application of biochemical markers of bone turnover.Osteoporosis: prevention and treatment in anorexia nervosa.Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra.Denosumab for the treatment of postmenopausal osteoporosis.The role of biochemical markers of bone turnover in osteoporosis management in clinical practice.Denosumab: a promising drug for the prevention and treatment of osteoporosis.An assessment of genetic markers as predictors of bone turnover in healthy adults.Vitamin K status in patients with Crohn's disease and relationship to bone turnover.25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population.Bone mineral density in ambulatory children with epilepsy.
P2860
Q33545020-1D75AE97-C004-4C18-A54C-54275B21B124Q33685092-AE1461CD-109B-4197-A480-D21F030B2D3BQ33746674-8E19478D-66BE-4720-A187-D24984E74769Q33757735-4E8E7A41-16B7-4632-8A87-837AB0DFC35DQ34292278-FCA71113-2E69-4E4A-A077-97FF989EF36BQ35053491-15AA72A3-5770-4FAB-8722-1F22033F79D8Q35184707-5FC3EA3C-970D-4E03-9B90-9650FC70E5A5Q35195104-EDF0CAFF-C377-4324-985B-C853B3A5EE5EQ35195108-9D2C1AE7-FCAB-4096-9AAF-253B3C488E02Q35690132-4C81381F-283D-486D-82EF-43E867AF9B33Q35788591-E440D7DC-6DC8-4246-9D34-7FEABC2F8CE9Q36056922-59BC7E77-790A-47BD-B83C-63C1C483302BQ36408738-44E562D5-A271-4AAD-8418-DA534EDBB198Q36633388-EEF781C1-7C82-4F32-B16B-2B0B7ADE0BF4Q36658915-E45F7F9B-D7E2-4F8C-AE45-A8F4FA45B067Q36888634-9FA6EDB4-209B-4F61-991F-9E1FC95CFC75Q37233308-E62F1FA3-5588-4AC1-BE2E-1C41251B0D67Q37411037-0387F317-C00B-4A2E-8726-1664375DB69DQ43259341-CEEBF47C-1F18-41BA-8A3E-A3E603AA95F0Q43267044-945A4844-511A-4099-ABE0-D32BDB3610F2Q43624738-59E14C8F-C004-45EC-8544-A328EC276838Q45156937-F7FE4CB5-B679-498A-BAF7-9245C7BE40E3Q47344652-CBD09821-7F58-46B1-960C-81FF4108734DQ51059654-25D09AEE-5D7C-4F92-B837-B2185DD32429
P2860
Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Drug therapy for vertebral fra ...... termine antifracture efficacy.
@en
type
label
Drug therapy for vertebral fra ...... termine antifracture efficacy.
@en
prefLabel
Drug therapy for vertebral fra ...... termine antifracture efficacy.
@en
P2093
P1433
P1476
Drug therapy for vertebral fra ...... termine antifracture efficacy.
@en
P2093
Melton LJ 3rd
O'Fallon WM
P304
P356
10.1016/8756-3282(95)00502-1
P433
P577
1996-03-01T00:00:00Z